Skip to content
Clinical Trials – home

Central Finland Hospital District Central Finland Hospital Nova

Research site

Finland Hoitajantie 3, 40620 Jyvaskyla, Finland

  • 8 trials recruiting
  • Appendicitis · Embolism venous · Prostate cancer
  • Adults and children

About Specializations

Central Finland Hospital District Central Finland Hospital Nova in Jyvaskyla, Finland specialises in clinical trials of conditions such as Appendicitis, Embolism venous, Prostate cancer, Breast cancer, and other specialisations. This site conducts important research.

Main research areas of the site

Neoplasm Research at Central Finland Hospital District Central Finland Hospital Nova

This site supports clinical research in cancer care, with studies focused on breast cancer, prostate cancer, and colorectal cancer. The trials aim to improve treatment effectiveness, slow disease progression, and better understand outcomes for people with advanced or high-risk disease.

  • Testing new approaches to help delay progression in prostate cancer
  • Evaluating added treatment options for early-stage, high-risk breast cancer
  • Studying resectability, postoperative outcomes, and survival in metastatic colorectal cancer

This work reflects a strong focus on both treatment improvement and real-world cancer outcomes in Jyvaskyla.

Emergency and Acute Care Diagnostics

Clinical trials here also examine diagnostic techniques for urgent conditions, especially in patients with acute abdomen and reduced kidney function. The research is designed to improve the safety and accuracy of imaging choices in emergency care.

  • Comparing imaging strategies to improve diagnosis in acute abdominal pain
  • Assessing safer diagnostic options for patients with impaired renal function
  • Supporting better decision-making in urgent gastrointestinal evaluation

The emphasis is on improving diagnostic quality while reducing risk for vulnerable patients.

Surgical and Thrombosis Prevention Studies

The site conducts research in health care quality and therapeutics related to surgery, with trials addressing venous thromboembolism prevention. These studies look at how to balance protection from clots with bleeding risk in patients undergoing surgery.

  • Evaluating clot-prevention strategies in surgical patients
  • Studying the benefits and risks of anticoagulant use alongside standard care
  • Improving treatment decisions for patients at uncertain risk of VTE

This research supports safer perioperative care and more individualized prevention strategies.

Digestive System and Appendicitis Research

Another key area is digestive system disease, especially uncomplicated acute appendicitis. The trials aim to compare treatment approaches and strengthen evidence for effective, less invasive care.

  • Comparing antibiotic-based treatment strategies for acute appendicitis
  • Assessing which approach best supports recovery in appendiceal inflammation
  • Improving treatment choices for patients with confirmed appendicitis

This line of research helps clarify how to manage common emergency abdominal conditions more effectively.

Nervous System and Pediatric Prevention Studies

The trial portfolio includes work in nervous system diseases, with a focus on preventing infantile spasms in high-risk infants. These studies explore early intervention for children with conditions that increase the chance of severe seizure disorders.

  • Investigating prevention of infantile spasm syndrome in high-risk infants
  • Studying early treatment for children with tuberous sclerosis or major brain injury
  • Supporting better outcomes in pediatric neurology through preventive care

The goal is to reduce the risk of serious neurological complications during infancy.

Musculoskeletal and Connective Tissue Research

Research at Central Finland Hospital Nova also covers musculoskeletal and skin and connective tissue conditions, particularly Dupuytren's contracture. The studies compare treatment strategies to determine which options work best and offer good value for patients.

  • Comparing treatment approaches for Dupuytren's contracture
  • Evaluating effectiveness and long-term outcomes in hand contracture care
  • Supporting better treatment selection for connective tissue disorders

This research helps refine care for a condition that can limit hand function and daily activity.

Critical Care Research

The site participates in intensive care studies involving adults admitted with acute critical illness. These trials examine commonly used treatments to better understand which approaches improve outcomes in the ICU.

  • Assessing treatment strategies for adults newly admitted to the intensive care unit
  • Studying interventions used in urgent, high-acuity critical care
  • Improving evidence for everyday decision-making in intensive care medicine

The focus is on practical evidence that can support better care for seriously ill patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Hoitajantie 340620 JyvaskylaFinland
Recruiting now
8 trials
Conditions studied
16

More sites in JyvaskylaFinland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

17 clinical trials

Study Comparing Intravenous Contrast CT with Non-Contrast CT for Patients with Acute Abdominal Pain and Reduced Kidney Function Using Iohexol

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Iohexol
  • Sponsor:University Of Helsinki

Intensive care

Recruiting

Evaluation of enoxaparin, dalteparin, nadroparin, tinzaparin and human albumin in adults admitted to intensive care unit with acute critical illness

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Dalteparin Sodium
  • Sponsor:Region Hovedstaden

Study on the Effects of Fluorouracil and Capecitabine in Patients with Metastatic Colorectal Cancer

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:HUS-Yhtymae

Prevention of Infantile Spasms with Vigabatrin in High-Risk Children Under 1 Year Old: A Study for Patients with Tuberous Sclerosis or Large Vascular Brain Injury

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:Vigabatrin
  • Sponsor:HUS-Yhtymae

Embolism venous

Recruiting

Study on Apixaban for Preventing Blood Clots in Patients Undergoing Abdominal, Gynecologic, and Urologic Surgery

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:HUS-Yhtymae

Study Comparing Drug-Coated Balloon and Drug-Eluting Stents in Patients with Coronary Artery Disease at High Risk of Bleeding Using Acetylsalicylic Acid and Drug Combination

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Wellbeing Services County Of North Karelia Siun Sote

Prostate cancer

Recruiting

Study on Estradiol and Exercise to Reduce Side Effects of Androgen Deprivation Therapy in Prostate Cancer Patients

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Estradiol
  • Sponsor:Varsinais-Suomen hyvinvointialue

Prostate cancer+1

Recruiting

Study on Atorvastatin's Effect on Prostate Cancer Progression in Patients Undergoing Androgen Deprivation Therapy

Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Pirkanmaan hyvinvointialue

Embolism venous

Not yet recruiting

Apixaban for Preventing Blood Clots in Adults Receiving Neoadjuvant Therapy for Muscle‑Invasive Bladder Cancer

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:HUS-Yhtymae

Appendicitis

Not yet recruiting

Study on Antibiotic Treatment for Uncomplicated Acute Appendicitis Using Levofloxacin, Ertapenem, and Moxifloxacin in Adult Patients

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years
  • Substances:Ertapenem
  • Sponsor:Turku University Hospital

Appendicitis

Not yet recruiting

Study on Moxifloxacin for Treating Uncomplicated Acute Appendicitis in Adults

Registered drug
Countries:FinlandFinland
  • Participants:18–64 years
  • Substances:Moxifloxacin
  • Sponsor:Turku University Hospital

Endometriosis

Not yet recruiting

Study on Cabergoline for Pain and Fertility in Women with Endometriosis and Infertility

Registered drug
Countries:FinlandFinland
  • Participants:18–64 years
  • Substances:Cabergoline
  • Sponsor:Turku University Hospital
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.